First Eagle Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,104,225
| Closed | -$7.2M | – | 407 |
|
|
2024
Q2 | $7.2M | Buy |
1,104,225
+102,000
| +10% | +$665K | 0.02% | 216 |
|
|
2024
Q1 | $8.73M | Buy |
1,002,225
+95,000
| +10% | +$827K | 0.02% | 187 |
|
|
2023
Q4 | $10.4M | Buy |
907,225
+90,636
| +11% | +$1.04M | 0.02% | 136 |
|
|
2023
Q3 | $7.86M | Buy |
816,589
+226,700
| +38% | +$2.18M | 0.02% | 144 |
|
|
2023
Q2 | $6.28M | Buy |
589,889
+98,525
| +20% | +$1.05M | 0.02% | 169 |
|
|
2023
Q1 | $5.17M | Buy |
491,364
+150,834
| +44% | +$1.59M | 0.01% | 159 |
|
|
2022
Q4 | $4.22M | Buy |
340,530
+85,030
| +33% | +$1.05M | 0.01% | 147 |
|
|
2022
Q3 | $2.65M | Buy |
+255,500
| New | +$2.65M | 0.01% | 171 |
|